Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis

Circulation
Andrew J LegerAthan Kuliopulos

Abstract

Thrombin is the most potent agonist of platelets and plays a critical role in the development of arterial thrombosis. Human platelets express dual thrombin receptors, protease-activated receptor (PAR) 1 and PAR4; however, there are no therapeutic strategies that effectively target both receptors. Platelet aggregation studies demonstrated that PAR4 activity is markedly enhanced by thrombin-PAR1 interactions. A combination of bivalirudin (hirulog) plus a novel PAR4 pepducin antagonist, P4pal-i1, effectively inhibited aggregation of human platelets to even high concentrations of thrombin and prevented occlusion of carotid arteries in guinea pigs. Likewise, combined inhibition of PAR1 and PAR4 with small-molecule antagonists and pepducins was effective against carotid artery occlusion. Coimmunoprecipitation and fluorescence resonance energy transfer studies revealed that PAR1 and PAR4 associate as a heterodimeric complex in human platelets and fibroblasts. PAR1-PAR4 cofactoring was shown by acceleration of thrombin cleavage and signaling of PAR4 on coexpression with PAR1. We show that PAR1 and PAR4 form a stable heterodimer that enables thrombin to act as a bivalent functional agonist. These studies suggest that targeting the PAR1-...Continue Reading

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A B KellyL A Harker
Dec 13, 1994·Biochemistry·M A ParryS R Stone
Aug 26, 1998·Nature·M L KahnS R Coughlin
Mar 17, 1999·The Journal of Clinical Investigation·M L KahnS R Coughlin
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·P Andrade-GordonK B White
Apr 15, 2000·Nature·M Nakanishi-MatsuiS R Coughlin
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lidija CovicAthan Kuliopulos
Nov 2, 2002·Nature Medicine·Zaverio M Ruggeri
May 10, 2005·Nature Medicine·Nicole C KaneiderAthan Kuliopulos

❮ Previous
Next ❯

Citations

Nov 9, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·David Stegner, Bernhard Nieswandt
Aug 21, 2009·Journal of Thrombosis and Thrombolysis·Shepard D Weiner, LeRoy E Rabbani
Jun 28, 2007·Biochemistry·Marvin T Nieman, Alvin H Schmaier
Jul 31, 2013·Journal of Medicinal Chemistry·Mei-Kwan YauDavid P Fairlie
Oct 30, 2007·Nature Immunology·Nicole C KaneiderAthan Kuliopulos
Jan 4, 2012·Nature Reviews. Drug Discovery·Rithwik RamachandranMorley D Hollenberg
May 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Leila M SevignyAthan Kuliopulos
Oct 10, 2009·The Journal of Biological Chemistry·Robin J MarjoramSamuel A Santoro
Mar 14, 2012·The Journal of Biological Chemistry·Margaret R CunninghamRobin Plevin
Feb 10, 2012·The Journal of Biological Chemistry·María de la FuenteMarvin T Nieman
Jun 18, 2010·Journal of Cardiovascular Pharmacology·Richard L Verrier, Tuomo Nieminen
Nov 19, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Rafal Pawlinski, Michael Holinstat
Sep 2, 2010·Journal of Inflammation·Ram SharonyGiuseppe Pintucci
Aug 4, 2012·Hämostaseologie·T Wurster, A E May
Aug 9, 2012·Future Cardiology·Fabiana RolliniDominick J Angiolillo
Apr 16, 2014·International Journal of Molecular Sciences·Tejminder S SidhuJustin R Hamilton
Mar 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Joseph N McLaughlinAsrar B Malik
Nov 2, 2013·Cellular and Molecular Life Sciences : CMLS·Mohammad JaberRachel Bar-Shavit
Dec 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Julie QuoyerMichel Bouvier
Dec 7, 2007·The Journal of Pharmacology and Experimental Therapeutics·Jennifer L StrandeJohn E Baker
Jul 3, 2007·Current Cardiology Reports·Jonathan D Rich, Stephen D Wiviott
Nov 13, 2015·Expert Review of Cardiovascular Therapy·Udaya S TantryPaul A Gurbel
Aug 9, 2011·Expert Opinion on Investigational Drugs·Paul A GurbelUdaya S Tantry
Sep 24, 2011·International Journal of Inflammation·Arthur J Chu
Apr 11, 2015·Pharmacology & Therapeutics·Thomas A Mavrakanas, Yiannis S Chatzizisis
Feb 14, 2012·Pharmacology & Therapeutics·Hannah Lee, Justin R Hamilton
Apr 1, 2012·Drug Discovery Today. Technologies
Oct 31, 2015·Annual Review of Pharmacology and Toxicology·Ivone GomesLakshmi A Devi
Feb 1, 2011·Pharmacology & Therapeutics·Mark N AdamsJohn D Hooper
Mar 28, 2009·Thrombosis Research·Allison G DupontMauricio G Cohen
Nov 26, 2015·Bulletin of Experimental Biology and Medicine·A O ShpakovE A Shpakova
Nov 18, 2015·Cancer Metastasis Reviews·Marek Z WojtukiewiczKenneth V Honn
Jul 6, 2014·Thrombosis and Haemostasis·N BoknäsT L Lindahl
Nov 21, 2009·Annals of the New York Academy of Sciences·Jacquelyn MillerStephen W Hunt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.